In 2015, employers spent $482.5 billion on health insurance premiums. A significant portion of that spend was for musculoskeletal (MSK) care—second only to heart disease. MSK conditions affect all segments of the working population. They cause pain and discomfort for employees and create astronomical costs for employers.
In recent weeks, we’ve seen the strain placed on the American healthcare system by COVID-19. The pandemic has exacerbated an existing problem: There’s not enough care to go around.
